Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Notice to readers: Newly licensed smallpox vaccine to replace old smallpox vaccine
  • Published Date:
    February 29, 2008
  • Status:
    current
  • Language:
    English
Filetype[HTML]
View this content


This is an HTML document so it cannot be previewed.
To open, click the "View" button.
Details:
  • Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
  • Description:
    CDC has begun distribution of a new-generation smallpox vaccine, ACAM2000 (Acambis, Inc., Cambridge, Massachusetts), to civilian laboratory personnel, the military, and state public health preparedness programs. ACAM2000 is a live, vaccinia virus smallpox vaccine that was licensed for use in the United States by the Food and Drug Administration in August 2007 (1).* ACAM2000 will be replacing Dryvax smallpox vaccine (Wyeth Pharmaceuticals, Inc., Marietta, Pennsylvania) because of withdrawal of the Dryvax license. ACAM2000 is a live vaccinia virus derived from plaque purification cloning from Dryvax. The safety data available from the ACAM2000 clinical trials indicate a similar safety profile to Dryvax.

  • Subject:
  • Document Type:
    Journal Issue
  • Place as Subject:
    United States
  • Collection(s):
    Guidelines and Recommendations
  • Main Document Checksum:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. MMWR. Morbidity and mortality weekly report, Vol. 57, no. 8, February 29, 2008
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    February 29, 2008
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 57, no. 8
    File Type:
    Filetype[PDF - 280.20 KB]
  2. Vaccinia Virus Infections in Martial Arts Gym, Maryland, USA, 2008
    Personal Author:
    Hughes, Christine M.; Blythe, David; Li, Yu; Reddy, Ramani; Jordan, Carol; Edwards, Cindy; Adams, Celia; Conners, Holly; Rasa, Catherine; Wilby, Sue; Russell, Jamaal; Russo, Kelly S.; Somsel, Patricia; Wiedbrauk, Danny L.; Dougherty, Cindy; Allen, Christopher; Frace, Mike; Emerson, Ginny; Olson, Victoria A.; Smith, Scott K.; Braden, Zachary; Abel, Jason; Davidson, Whitni; Reynolds, Mary; Damon, Inger K.;
    Published Date:
    Apr 2011
    Source:
    Emerg Infect Dis. 17(4):730-733.
    Description:
    Vaccinia virus is an orthopoxvirus used in the live vaccine against smallpox. Vaccinia virus infections can be transmissible and can cause severe complications in those with weakened immune systems. We report on a cluster of 4 cases of vaccinia virus...
    File Type:
    Filetype[PDF - 286.64 KB]
  3. CDC interim guidance for revaccination of eligible persons who participated in the US civilian smallpox preparedness and response program
    Corporate Authors:
    National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology.
    Published Date:
    12/06/2016
    Description:
    October 2008Purpose: The purpose of this document is to propose a recommendation for an appropriate time-interval for revaccination of public health and health care volunteers who were vaccinated as responders in the US Civilian Smallpox Preparedness...
    File Type:
    Filetype[PDF - 198.97 KB]
  4. MMWR. Morbidity and mortality weekly report, Vol. 65, no. 10, March 18, 2016
    Published Date:
    March 18, 2016
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 65, no. 10
    File Type:
    Filetype[PDF - 527.00 KB]
  5. MMWR. Morbidity and mortality weekly report, Vol. 48, no. 12, April 2, 1999
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    April 2, 1999
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 48, no. 12
    File Type:
    Filetype[PDF - 265.01 KB]